Streamline Health Solutions, Inc. is engaged in providing healthcare information technology through the licensing of its Electronic Health Information Management, Patient Financial, Coding and Clinical Documentation Improvement (CDI), and other Workflow software applications, and the use of such applications by software as a service. The Company also provides implementation and consulting services to complement its software solutions. The Company provides computer software-based solutions through its Looking Glass platform. The Company sells its solutions and services in North America to hospitals and health systems, including physician practices, through its direct sales force and its reseller partnerships. The Company's software and services allow hospitals and integrated healthcare delivery systems in the United States and Canada to capture, store, manage, route, retrieve and process patient clinical, financial and other healthcare provider information.
Industry, Sector and Symbol:
- Sector: Medical
- Industry: Healthcare Facilities & Services
- Sub-Industry: N/A
- Symbol: NASDAQ:STRM
- CUSIP: N/A
- Web: www.streamlinehealth.net
Capitalization:- Market Cap: $27.98 million
- Outstanding Shares: 19,695,000
Average Prices:- 50 Day Moving Avg: $1.21
- 200 Day Moving Avg: $1.18
- 52 Week Range: $0.85 - $2.11
P/E:- Trailing P/E Ratio: N/A
- Foreward P/E Ratio: -6.81
- P/E Growth: -0.37
Sales & Book Value:- Annual Revenue: $26.32 million
- Price / Sales: 1.07
- Book Value: $0.51 per share
- Price / Book: 2.80
Profitability:- EBIDTA: ($3,170,000.00)
- Net Margins: -24.50%
- Return on Equity: -56.04%
- Return on Assets: -15.49%
Debt:- Debt-to-Equity Ratio: 0.45%
- Current Ratio: 0.76%
- Quick Ratio: 0.76%
Misc:- Average Volume: 52,056 shs.
- Beta: 0.16
- Short Ratio: 2.06
Frequently Asked Questions for Streamline Health Solutions (NASDAQ:STRM)
What is Streamline Health Solutions' stock symbol?
Streamline Health Solutions trades on the NASDAQ under the ticker symbol "STRM."
How were Streamline Health Solutions' earnings last quarter?
Streamline Health Solutions, Inc. (NASDAQ:STRM) issued its earnings results on Wednesday, September, 13th. The company reported ($0.06) EPS for the quarter, beating the Zacks' consensus estimate of ($0.09) by $0.03. The business had revenue of $5.92 million for the quarter, compared to the consensus estimate of $6.54 million. Streamline Health Solutions had a negative net margin of 24.50% and a negative return on equity of 56.04%. View Streamline Health Solutions' Earnings History.
Who are some of Streamline Health Solutions' key competitors?
Some companies that are related to Streamline Health Solutions include Dipexium Pharmaceuticals (PLXP), Fibrocell Science (FCSC), Trillium Therapeutics (TRIL), KemPharm (KMPH), Evoke Pharma (EVOK), Xenon Pharmaceuticals (XENE), Leap Therapeutics (LPTX), OvaScience (OVAS), Aldeyra Therapeutics (ALDX), Proteostasis Therapeutics (PTI), IntelGenx Technologies Corp. (IGXT), Juniper Pharmaceuticals (JNP), pSivida Corp. (PSDV), Aevi Genomic Medicine (GNMX), Microbot Medical (MBOT), Biolase (BIOL), Histogenics Corporation (HSGX) and Ohr Pharmaceuticals (OHRP).
Who are Streamline Health Solutions' key executives?
Streamline Health Solutions' management team includes the folowing people:
- Jonathan R. Phillips, Independent Chairman of the Board
- David William Sides, President, Chief Executive Officer
- Nicholas A. Meeks, Chief Financial Officer, Senior Vice President, Principal Accounting Officer
- Randolph W. Salisbury, Senior Vice President, Chief Marketing Officer
- Shaun L. Priest, Senior Vice President and Chief Growth Officer
- Lois E. Rickard, Senior Vice President and Chief People Officer
- Judith E. Starkey, Director
- Michael K. Kaplan, Independent Director
- Allen S. Moseley, Independent Director
- Michael G. Valentine, Independent Director
Who owns Streamline Health Solutions stock?
Streamline Health Solutions' stock is owned by a number of of retail and institutional investors. Top institutional shareholders include First Light Asset Management LLC (8.99%), Tamarack Advisers LP (5.78%), Kennedy Capital Management Inc. (2.71%), Vanguard Group Inc. (0.85%), LifePlan Financial Group Inc (0.61%) and Palisade Capital Management LLC NJ (0.58%). Company insiders that own Streamline Health Solutions stock include David William Sides, Jack William Jr Kennedy, James E Flynn, Jonathan R Phillips, Judith Starkey, Michael K Kaplan, Nicholas Meeks, Randolph Salisbury and Shaun Linwood Priest. View Institutional Ownership Trends for Streamline Health Solutions.
Who sold Streamline Health Solutions stock? Who is selling Streamline Health Solutions stock?
Who bought Streamline Health Solutions stock? Who is buying Streamline Health Solutions stock?
Streamline Health Solutions' stock was bought by a variety of institutional investors in the last quarter, including Kennedy Capital Management Inc. and First Light Asset Management LLC. Company insiders that have bought Streamline Health Solutions stock in the last two years include David William Sides, Jack William Jr Kennedy, Jonathan R Phillips, Judith Starkey, Michael K Kaplan, Nicholas Meeks, Randolph Salisbury and Shaun Linwood Priest. View Insider Buying and Selling for Streamline Health Solutions.
How do I buy Streamline Health Solutions stock?
Shares of Streamline Health Solutions can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Streamline Health Solutions' stock price today?
One share of Streamline Health Solutions stock can currently be purchased for approximately $1.43.
MarketBeat Community Rating for Streamline Health Solutions (NASDAQ STRM)MarketBeat's community ratings are surveys of what our community members think about Streamline Health Solutions and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
Consensus Ratings for Streamline Health Solutions (NASDAQ:STRM) (How are Consensus Ratings Calculated?) MarketBeat calculates consensus ratings using the most recent rating from each brokerage that has rated a stock within the last twelve months. Since brokers often use different ratings systems, each rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings. Each stock's consensus rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months.
MarketBeat will no longer include ratings and price target data in its consensus calculation if a broker drops coverage and MarketBeat has received a report that coverage was dropped. Ratings from certain research firms that issue ratings using purely quantitative methods (such as Zacks, Vetr and ValuEngine) are not included in consensus calculations. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
| Ratings Breakdown: | No ratings tracked in the last 12 months. |
| Consensus Rating: | N/A (Score: NaN) |
| Consensus Price Target: | N/A |
Analysts' Ratings History for Streamline Health Solutions (NASDAQ:STRM)
Show:
| Date | Firm | Action | Rating | Price Target | Impact on Share Price | Details |
|---|
| 4/25/2016 | Lake Street Capital | Downgrade | Buy -> Hold | | N/A |  |
(Data available from 9/24/2015 forward)
Earnings History for Streamline Health Solutions (NASDAQ:STRM)Earnings History by Quarter for Streamline Health Solutions (NASDAQ STRM)| Date | Quarter | Consensus Estimate | Actual EPS | Revenue Estimate | Actual Revenue | Release Link | Conference Call | Details |
|---|
| 9/13/2017 | Q2 | ($0.09) | ($0.06) | $6.54 million | $5.92 million | View | N/A | |
| 6/12/2017 | Q1 2018 | ($0.10) | ($0.10) | | $5.92 million | View | N/A | |
| 9/7/2016 | Q216 | ($0.08) | ($0.06) | $7.02 million | $7.40 million | View | N/A | |
| 6/8/2016 | Q116 | ($0.10) | ($0.10) | $6.88 million | $6.70 million | View | N/A | |
| 4/20/2016 | Q415 | ($0.09) | ($0.09) | $7.34 million | $6.40 million | View | Listen | |
| 12/10/2015 | Q315 | ($0.11) | ($0.04) | $7.20 million | $7.30 million | View | Listen | |
| 9/3/2015 | Q215 | ($0.12) | ($0.05) | $7.23 million | $8.60 million | View | N/A | |
| 6/9/2015 | Q115 | ($0.12) | ($0.12) | $7.47 million | $6.20 million | View | N/A | |
| 4/16/2015 | Q414 | ($0.16) | ($0.28) | $7.03 million | $6.60 million | View | N/A | |
| 12/10/2014 | Q314 | ($0.13) | ($0.14) | $7.24 million | $6.80 million | View | N/A | |
| 9/9/2014 | Q2 14 | ($0.11) | ($0.14) | $7.40 million | $7.24 million | View | N/A | |
| 12/12/2013 | Q3 | ($0.21) | ($0.50) | $6.53 million | $6.70 million | View | Listen | |
| 9/9/2013 | Q2 2013 | | ($0.07) | $5.05 million | $8.80 million | View | N/A | |
(Data available from 1/1/2011 forward)
Earnings Estimates for Streamline Health Solutions (NASDAQ:STRM)2017 EPS Consensus Estimate: ($0.37)
2019 EPS Consensus Estimate: ($0.21)
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|
| Q1 2017 | 1 | ($0.11) | ($0.11) | ($0.11) |
| Q2 2017 | 1 | ($0.10) | ($0.10) | ($0.10) |
| Q3 2017 | 1 | ($0.08) | ($0.08) | ($0.08) |
| Q4 2017 | 1 | ($0.08) | ($0.08) | ($0.08) |
| Q1 2019 | 1 | ($0.09) | ($0.09) | ($0.09) |
| Q2 2019 | 1 | ($0.07) | ($0.07) | ($0.07) |
| Q3 2019 | 1 | ($0.07) | ($0.07) | ($0.07) |
| Q4 2019 | 1 | $0.02 | $0.02 | $0.02 |
(Data provided by Zacks Investment Research)
Dividend History for Streamline Health Solutions (NASDAQ:STRM)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading and Institutional Ownership History for Streamline Health Solutions (NASDAQ:STRM)Insider Ownership Percentage: 26.10%
Institutional Ownership Percentage: 38.53%
Insider Trades by Quarter for Streamline Health Solutions (NASDAQ:STRM)| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Details |
|---|
| 6/28/2017 | Shaun Linwood Priest | SVP | Buy | 1,000 | $0.99 | $990.00 | |
| 6/27/2017 | Shaun Linwood Priest | SVP | Buy | 800 | $0.99 | $792.00 | |
| 6/19/2017 | Jonathan R. Phillips | Director | Buy | 10,000 | $1.10 | $11,000.00 | |
| 6/15/2017 | Shaun Linwood Priest | SVP | Buy | 10,000 | $1.03 | $10,300.00 | |
| 4/13/2017 | David William Sides | CEO | Buy | 5,000 | $1.30 | $6,500.00 | |
| 4/13/2017 | Michael K. Kaplan | Director | Buy | 10,000 | $1.17 | $11,700.00 | |
| 4/13/2017 | Shaun Linwood Priest | SVP | Buy | 21,000 | $1.25 | $26,250.00 | |
| 1/9/2017 | Shaun Linwood Priest | SVP | Buy | 1,387 | $1.24 | $1,719.88 | |
| 12/28/2016 | Shaun Linwood Priest | SVP | Buy | 11,488 | $1.29 | $14,819.52 | |
| 12/12/2016 | David William Sides | CEO | Buy | 10,000 | $1.36 | $13,600.00 | |
| 12/12/2016 | Michael K. Kaplan | Director | Buy | 5,000 | $1.35 | $6,750.00 | |
| 10/7/2016 | Shaun Linwood Priest | SVP | Buy | 10,381 | $1.89 | $19,620.09 | |
| 9/19/2016 | Shaun Linwood Priest | SVP | Buy | 23,400 | $1.66 | $38,844.00 | |
| 9/16/2016 | David William Sides | CEO | Buy | 1,000 | $1.63 | $1,630.00 | |
| 9/14/2016 | Shaun Linwood Priest | SVP | Buy | 1,774 | $1.55 | $2,749.70 | |
| 9/13/2016 | Jonathan R. Phillips | Director | Buy | 10,000 | $1.60 | $16,000.00 | |
| 1/13/2016 | David William Sides | CEO | Buy | 90,000 | $1.66 | $149,400.00 | |
| 1/13/2016 | Randolph Salisbury | CMO | Buy | 30,000 | $1.51 | $45,300.00 | |
| 1/12/2016 | David William Sides | CEO | Buy | 80,000 | $1.64 | $131,200.00 | |
| 1/12/2016 | Judith Starkey | Director | Buy | 50,000 | $1.70 | $85,000.00 | |
| 1/11/2016 | David William Sides | CEO | Buy | 26,910 | $1.49 | $40,095.90 | |
| 1/11/2016 | Jack William Jr. Kennedy | SVP | Buy | 11,400 | $1.46 | $16,644.00 | |
| 1/11/2016 | Michael K Kaplan | Director | Buy | 35,000 | $1.50 | $52,500.00 | |
| 1/11/2016 | Nicholas Meeks | CFO | Buy | 6,000 | $1.46 | $8,760.00 | |
| 12/17/2015 | James E Flynn | Insider | Sell | 397,259 | $1.23 | $488,628.57 | |
| 1/20/2015 | Jack William Jr. Kennedy | SVP | Buy | 1,000 | $3.54 | $3,540.00 | |
| 1/20/2015 | Michael K Kaplan | Director | Buy | 5,000 | $3.54 | $17,700.00 | |
| 1/12/2015 | David William Sides | CEO | Buy | 5,000 | $4.09 | $20,450.00 | |
| 12/23/2014 | David William Sides | COO | Buy | 10,000 | $3.83 | $38,300.00 | |
| 12/16/2014 | David William Sides | COO | Buy | 12,500 | $3.93 | $49,125.00 | |
| 12/15/2014 | David William Sides | COO | Buy | 7,500 | $3.91 | $29,325.00 | |
| 9/26/2014 | David William Sides | COO | Buy | 10,000 | $3.91 | $39,100.00 | |
| 9/23/2014 | Andrew L Turner | Director | Sell | 17,567 | $3.83 | $67,281.61 | |
| 9/22/2014 | Jack William Jr. Kennedy | SVP | Buy | 3,000 | $3.84 | $11,520.00 | |
| 9/22/2014 | Nicholas Meeks | CFO | Buy | 1,000 | $3.84 | $3,840.00 | |
| 9/19/2014 | David William Sides | COO | Buy | 2,500 | $3.82 | $9,550.00 | |
| 9/19/2014 | Robert Eugene Watson | CEO | Buy | 5,000 | $3.92 | $19,600.00 | |
| 9/18/2014 | David William Sides | COO | Buy | 8,000 | $4.00 | $32,000.00 | |
| 9/18/2014 | Jonathan R Phillips | Director | Buy | 5,000 | $3.90 | $19,500.00 | |
| 8/21/2014 | Jack William Jr. Kennedy | SVP | Buy | 3,000 | $4.28 | $12,840.00 | |
| 8/21/2014 | Michael K Kaplan | Director | Buy | 20,000 | $4.28 | $85,600.00 | |
| 8/21/2014 | Nicholas Meeks | CFO | Buy | 1,000 | $4.28 | $4,280.00 | |
| 8/21/2014 | Richard Nelli | COO | Buy | 2,000 | $4.28 | $8,560.00 | |
| 8/21/2014 | Robert Eugene Watson | CEO | Buy | 10,000 | $4.28 | $42,800.00 | |
| 12/31/2013 | Herbert Larsen | VP | Buy | 1,058 | $5.67 | $5,998.86 | |
| 12/27/2013 | Andrew Turner | Director | Sell | 25,000 | $6.63 | $165,750.00 | |
| 8/13/2013 | Richard C Levy | Director | Buy | 40,000 | $3.85 | $154,000.00 | |
| 7/3/2013 | Richard C Levy | Director | Sell | 22,000 | $6.91 | $152,020.00 | |
| 7/1/2013 | Michael A Schiller | VP | Buy | 4,731 | $3.17 | $14,997.27 | |
| 6/26/2013 | Herbert P Larsen | VP | Buy | 2,700 | $6.11 | $16,497.00 | |
| 6/19/2013 | Michael G Valentine | Director | Buy | 33,000 | $6.06 | $199,980.00 | |
| 5/6/2013 | Gary M Winzenread | Insider | Sell | 37,173 | $6.29 | $233,818.17 | |
| 4/30/2013 | Jonathan R Phillips | Director | Buy | 5,000 | $6.27 | $31,350.00 | |
| 4/30/2013 | Robert Eugene Watson | CEO | Buy | 1,750 | $6.28 | $10,990.00 | |
| 4/29/2013 | Michael A Schiller | VP | Buy | 1,000 | $6.10 | $6,100.00 | |
| 12/26/2012 | Jonathan R Phillips | Director | Buy | 15,000 | $5.13 | $76,950.00 | |
| 10/26/2012 | Jay D Miller | Director | Buy | 3,400 | $4.16 | $14,144.00 | |
| 10/26/2012 | Robert Eugene Watson | CEO | Buy | 7,140 | $4.16 | $29,702.40 | |
| 9/25/2012 | Jonathan R Phillips | Director | Buy | 3,000 | $4.99 | $14,970.00 | |
(Data available from 1/1/2013 forward)
Headline Trends for Streamline Health Solutions (NASDAQ:STRM)
Latest Headlines for Streamline Health Solutions (NASDAQ:STRM)
| Source: |
|
| Date | Headline |
|---|
 | ETFs with exposure to Streamline Health Solutions, Inc. : September 19, 2017
finance.yahoo.com - September 20 at 9:35 AM |
| ETFs with exposure to Streamline Health Solutions, Inc. : September 19, 2017
finance.yahoo.com - September 20 at 9:35 AM |
| Streamline Health Solutions, Inc. :STRM-US: Earnings Analysis: Q2, 2018 By the Numbers : September 18, 2017
finance.yahoo.com - September 19 at 8:09 AM |
 | BRIEF-Streamline Health Solutions reports Q2 net loss per common share $0.06
www.reuters.com - September 15 at 9:30 AM |
| Edited Transcript of STRM earnings conference call or presentation 14-Sep-17 1:00pm GMT
finance.yahoo.com - September 15 at 9:30 AM |
| Edited Transcript of STRM earnings conference call or presentation 14-Sep-17 1:00pm GMT
finance.yahoo.com - September 15 at 9:30 AM |
| Streamline Health® Reports Second Quarter 2017 Revenues Of $5.9 Million; ($1.1 Million) Net Loss; Adjusted EBITDA Of $0.5 Million
finance.yahoo.com - September 14 at 10:44 AM |
 | Streamline Health Solutions, Inc. (STRM) Issues Earnings Results, Beats Estimates By $0.03 EPS
www.americanbankingnews.com - September 14 at 9:16 AM |
| Contrasting Laboratory Corporation of America Holdings (LH) and Streamline Health Solutions (STRM)
www.americanbankingnews.com - September 13 at 10:34 PM |
| Head to Head Review: Streamline Health Solutions (STRM) versus its Rivals
www.americanbankingnews.com - September 10 at 10:40 AM |
| Streamline Health® to Report Second Quarter 2017 Financial Results on Wednesday, September 13, 2017
finance.yahoo.com - September 7 at 9:33 AM |
| Streamline Health® to Report Second Quarter 2017 Financial Results on Wednesday, September 13, 2017
finance.yahoo.com - September 7 at 9:33 AM |
| Chicago's South Shore Hospital Signs Contract For Streamline Health's® eValuator™ Software
finance.yahoo.com - September 1 at 9:10 AM |
| Zacks Investment Research Downgrades Streamline Health Solutions, Inc. (STRM) to Hold
www.americanbankingnews.com - August 21 at 9:48 PM |
| Reviewing Streamline Health Solutions (STRM) & Quest Diagnostics (DGX)
www.americanbankingnews.com - August 20 at 10:12 PM |
| ETFs with exposure to Streamline Health Solutions, Inc. : June 30, 2017
finance.yahoo.com - July 1 at 7:55 AM |
| Streamline Health Solutions, Inc. (STRM) Rating Increased to Buy at Zacks Investment Research
www.americanbankingnews.com - June 21 at 9:37 AM |
| ETFs with exposure to Streamline Health Solutions, Inc. : June 20, 2017
finance.yahoo.com - June 21 at 5:58 AM |
| Streamline Health Solutions, Inc. (STRM) Director Acquires $11,000.00 in Stock
www.americanbankingnews.com - June 20 at 4:22 PM |
| Streamline Health Solutions, Inc. :STRM-US: Earnings Analysis: Q1, 2018 By the Numbers : June 19, 2017
finance.yahoo.com - June 20 at 8:15 AM |
| FY2019 Earnings Estimate for Streamline Health Solutions, Inc. Issued By Craig Hallum (STRM)
www.americanbankingnews.com - June 19 at 7:54 AM |
| Streamline Health Solutions, Inc. (STRM) SVP Buys $10,300.00 in Stock
www.americanbankingnews.com - June 16 at 1:47 PM |
| Edited Transcript of STRM earnings conference call or presentation 13-Jun-17 1:00pm GMT
finance.yahoo.com - June 14 at 1:09 AM |
 | Streamline Health Q1 top line down 11%; shares ease 8%
seekingalpha.com - June 13 at 8:08 PM |
| Investor Network: Streamline Health Solutions, Inc. to Host Earnings Call
finance.yahoo.com - June 13 at 9:41 AM |
| Streamline Health Solutions, Inc. (STRM) Posts Quarterly Earnings Results, Meets Expectations
www.americanbankingnews.com - June 13 at 8:48 AM |
| BRIEF-Streamline Health Solutions Q1 revenue fell 11 pct to $5.9 million
www.reuters.com - June 12 at 7:32 PM |
| Streamline Health® Reports First Quarter 2017 Revenues Of $5.9 Million; $(2.0) Million Net Loss; Adjusted EBITDA Of $(0.4) Million
finance.yahoo.com - June 12 at 7:32 PM |
| Streamline Health® to Report First Quarter 2017 Financial Results on Monday, June 12, 2017
finance.yahoo.com - June 7 at 10:20 AM |
| Streamline Health Solutions Inc. (STRM) Sees Large Drop in Short Interest
www.americanbankingnews.com - June 6 at 9:20 AM |
| Streamline Health Solutions Inc. (STRM) Rating Increased to Sell at ValuEngine
www.americanbankingnews.com - June 3 at 8:56 AM |
| Streamline Health Solutions Inc. (STRM) Expected to Announce Earnings of -$0.10 Per Share
www.americanbankingnews.com - June 1 at 8:36 AM |
| ValuEngine Lowers Streamline Health Solutions Inc. (STRM) to Strong Sell
www.americanbankingnews.com - May 17 at 3:26 PM |
| Streamline Health® To Promote New eValuator™ Automated Coding/Data Analysis Software At The Annual ACDIS Convention
finance.yahoo.com - May 8 at 7:32 PM |
| -$0.10 Earnings Per Share Expected for Streamline Health Solutions Inc. (STRM) This Quarter
www.americanbankingnews.com - May 6 at 12:04 AM |
| Streamline Health Solutions (STRM) Getting Positive Press Coverage, Study Finds
www.americanbankingnews.com - May 2 at 3:40 PM |
| Streamline Health Solutions (STRM) Earning Very Positive Media Coverage, Report Finds
www.americanbankingnews.com - April 29 at 9:42 AM |
| Streamline Health Solutions (STRM) Receiving Favorable Media Coverage, Analysis Finds
www.americanbankingnews.com - April 21 at 4:42 PM |
| Streamline Health Solutions Inc. (STRM) Cut to Hold at Zacks Investment Research
www.americanbankingnews.com - April 19 at 9:33 AM |
| Streamline Health Solutions (STRM) Receiving Positive News Coverage, Study Shows
www.americanbankingnews.com - April 18 at 3:36 PM |
 | Monday 4/17 Insider Buying Report: STRM, ASPN
www.nasdaq.com - April 17 at 6:58 PM |
| Streamline Health Solutions Inc. (STRM) to Release Earnings on Tuesday
www.americanbankingnews.com - April 16 at 7:18 AM |
| Streamline Health Solutions (STRM) Earning Very Favorable Media Coverage, AlphaOne Reports
www.americanbankingnews.com - April 15 at 9:07 AM |
| Streamline Health Solutions Inc. (STRM) Lifted to "Buy" at Zacks Investment Research
www.americanbankingnews.com - April 15 at 7:19 AM |
| Michael K. Kaplan Buys 10,000 Shares of Streamline Health Solutions Inc. (STRM) Stock
www.americanbankingnews.com - April 14 at 7:40 PM |
| Insider Buying: Streamline Health Solutions Inc. (STRM) SVP Purchases 21,000 Shares of Stock
www.americanbankingnews.com - April 14 at 7:40 PM |
| First Analysis Comments on Streamline Health Solutions Inc.'s FY2018 Earnings (STRM)
www.americanbankingnews.com - April 14 at 2:42 PM |
| ETFs with exposure to Streamline Health Solutions, Inc. : April 13, 2017
finance.yahoo.com - April 13 at 7:53 PM |
| Streamline Health Solutions, Inc. :STRM-US: Earnings Analysis: Q4, 2017 By the Numbers : April 12, 2017
finance.yahoo.com - April 12 at 12:51 PM |
| Edited Transcript of STRM earnings conference call or presentation 10-Apr-17 9:00pm GMT
finance.yahoo.com - April 11 at 7:47 PM |
Streamline Health Solutions (STRM) Chart for Sunday, September, 24, 2017
